苏州旺山旺水生物医药股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
2
NMPA:2
Drug Approvals
Dapoxetine Hydrochloride Tablets
- Product Name
- 盐酸达泊西汀片
- Approval Number
- 国药准字H20234430
- Approval Date
- Oct 27, 2023
NMPA
Clinical Trials
No trials found
News
No news found